Immunomodulator Vitamin C: An Adjuvant Therapy in Second Wave of Coronavirus Disease 2019
Since its sudden outbreak in December 2019 in Wuhan, A pandemic of SARS-CoV-2 has been announced. Vitamin C is a water-soluble vitamin with anti-oxidant and immunity-boosting properties. Vitamin C acts as a nutritional supplement profoundly impacting the immune response to the second or third wave o...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Journal of Pure and Applied Microbiology
2022-09-01
|
| Series: | Journal of Pure and Applied Microbiology |
| Subjects: | |
| Online Access: | https://microbiologyjournal.org/immunomodulator-vitamin-c-an-adjuvant-therapy-in-second-wave-of-coronavirus-disease-2019/ |
| _version_ | 1811205948569550848 |
|---|---|
| author | Pradeep Kumar Manish Kumar Verma Rachna Sharma Rohit Agrawal Shashi Prabha Singh Anoop Jaiswal Om Prakash Navneet Soni Preeti Sharma |
| author_facet | Pradeep Kumar Manish Kumar Verma Rachna Sharma Rohit Agrawal Shashi Prabha Singh Anoop Jaiswal Om Prakash Navneet Soni Preeti Sharma |
| author_sort | Pradeep Kumar |
| collection | DOAJ |
| description | Since its sudden outbreak in December 2019 in Wuhan, A pandemic of SARS-CoV-2 has been announced. Vitamin C is a water-soluble vitamin with anti-oxidant and immunity-boosting properties. Vitamin C acts as a nutritional supplement profoundly impacting the immune response to the second or third wave of the coronavirus disease (COVID-19). Vitamin C efficacy as an adjuvant treatment for inflammation and symptoms associated with COVID-19 infection should be investigated further. This report sheds light on the available information on the current clinical trials and pharmacotherapy related to COVID-19. Information available on Pubmed, EMBASE, Scopus, Web of Science databases and EU clinical trials regarding the use of therapeutic agents in patients with COVID-19 was used to perform analysis. Data was taken from 18 clinical trials available in the U.S. National Library of Medicine. All trials that are active, completed, or in the process of recruiting are included in data. Because of majority of clinical trials are still ongoing, specific results and high-quality clinical evidence are lacking. Before being standardised for use, the protocol must undergo large randomised clinical studies using a variety of existing medications and potential therapies. The pivotal role played by vitamins C in maintaining our immune system, is quite apparent. This review is an attempt to summarize the available information regarding the use of vitamin C as an adjuvant therapy in COVID-19 patients. |
| first_indexed | 2024-04-12T03:39:45Z |
| format | Article |
| id | doaj.art-4c08ab909cd947f1bd6f47ea3fb4c61c |
| institution | Directory Open Access Journal |
| issn | 0973-7510 2581-690X |
| language | English |
| last_indexed | 2024-04-12T03:39:45Z |
| publishDate | 2022-09-01 |
| publisher | Journal of Pure and Applied Microbiology |
| record_format | Article |
| series | Journal of Pure and Applied Microbiology |
| spelling | doaj.art-4c08ab909cd947f1bd6f47ea3fb4c61c2022-12-22T03:49:19ZengJournal of Pure and Applied MicrobiologyJournal of Pure and Applied Microbiology0973-75102581-690X2022-09-0116314651478https://doi.org/10.22207/JPAM.16.3.46Immunomodulator Vitamin C: An Adjuvant Therapy in Second Wave of Coronavirus Disease 2019Pradeep Kumarhttps://orcid.org/0000-0002-4550-1699Manish Kumar Vermahttps://orcid.org/0000-0003-2618-4277Rachna Sharmahttps://orcid.org/0000-0002-0379-1122Rohit AgrawalShashi Prabha SinghAnoop JaiswalOm PrakashNavneet SoniPreeti Sharmahttps://orcid.org/0000-0002-9612-4627Since its sudden outbreak in December 2019 in Wuhan, A pandemic of SARS-CoV-2 has been announced. Vitamin C is a water-soluble vitamin with anti-oxidant and immunity-boosting properties. Vitamin C acts as a nutritional supplement profoundly impacting the immune response to the second or third wave of the coronavirus disease (COVID-19). Vitamin C efficacy as an adjuvant treatment for inflammation and symptoms associated with COVID-19 infection should be investigated further. This report sheds light on the available information on the current clinical trials and pharmacotherapy related to COVID-19. Information available on Pubmed, EMBASE, Scopus, Web of Science databases and EU clinical trials regarding the use of therapeutic agents in patients with COVID-19 was used to perform analysis. Data was taken from 18 clinical trials available in the U.S. National Library of Medicine. All trials that are active, completed, or in the process of recruiting are included in data. Because of majority of clinical trials are still ongoing, specific results and high-quality clinical evidence are lacking. Before being standardised for use, the protocol must undergo large randomised clinical studies using a variety of existing medications and potential therapies. The pivotal role played by vitamins C in maintaining our immune system, is quite apparent. This review is an attempt to summarize the available information regarding the use of vitamin C as an adjuvant therapy in COVID-19 patients.https://microbiologyjournal.org/immunomodulator-vitamin-c-an-adjuvant-therapy-in-second-wave-of-coronavirus-disease-2019/coronavirus infectionvitamin c (ascorbic acid)antiviral agentssevere acute respiratory syndrome |
| spellingShingle | Pradeep Kumar Manish Kumar Verma Rachna Sharma Rohit Agrawal Shashi Prabha Singh Anoop Jaiswal Om Prakash Navneet Soni Preeti Sharma Immunomodulator Vitamin C: An Adjuvant Therapy in Second Wave of Coronavirus Disease 2019 Journal of Pure and Applied Microbiology coronavirus infection vitamin c (ascorbic acid) antiviral agents severe acute respiratory syndrome |
| title | Immunomodulator Vitamin C: An Adjuvant Therapy in Second Wave of Coronavirus Disease 2019 |
| title_full | Immunomodulator Vitamin C: An Adjuvant Therapy in Second Wave of Coronavirus Disease 2019 |
| title_fullStr | Immunomodulator Vitamin C: An Adjuvant Therapy in Second Wave of Coronavirus Disease 2019 |
| title_full_unstemmed | Immunomodulator Vitamin C: An Adjuvant Therapy in Second Wave of Coronavirus Disease 2019 |
| title_short | Immunomodulator Vitamin C: An Adjuvant Therapy in Second Wave of Coronavirus Disease 2019 |
| title_sort | immunomodulator vitamin c an adjuvant therapy in second wave of coronavirus disease 2019 |
| topic | coronavirus infection vitamin c (ascorbic acid) antiviral agents severe acute respiratory syndrome |
| url | https://microbiologyjournal.org/immunomodulator-vitamin-c-an-adjuvant-therapy-in-second-wave-of-coronavirus-disease-2019/ |
| work_keys_str_mv | AT pradeepkumar immunomodulatorvitamincanadjuvanttherapyinsecondwaveofcoronavirusdisease2019 AT manishkumarverma immunomodulatorvitamincanadjuvanttherapyinsecondwaveofcoronavirusdisease2019 AT rachnasharma immunomodulatorvitamincanadjuvanttherapyinsecondwaveofcoronavirusdisease2019 AT rohitagrawal immunomodulatorvitamincanadjuvanttherapyinsecondwaveofcoronavirusdisease2019 AT shashiprabhasingh immunomodulatorvitamincanadjuvanttherapyinsecondwaveofcoronavirusdisease2019 AT anoopjaiswal immunomodulatorvitamincanadjuvanttherapyinsecondwaveofcoronavirusdisease2019 AT omprakash immunomodulatorvitamincanadjuvanttherapyinsecondwaveofcoronavirusdisease2019 AT navneetsoni immunomodulatorvitamincanadjuvanttherapyinsecondwaveofcoronavirusdisease2019 AT preetisharma immunomodulatorvitamincanadjuvanttherapyinsecondwaveofcoronavirusdisease2019 |